Healthy News For A Healthy You

Exploring topics on nutrition, safety, legalities, retirement, and more!

  • Home
    Home This is where you can find all the blog posts throughout the site.
  • Categories
    Categories Displays a list of categories from this blog.
  • Tags
    Tags Displays a list of tags that have been used in the blog.
Subscribe to this list via RSS Blog posts tagged in diabetic medication

Monitoring blood sugar levels, carbohydrate intake, and medications are daily tasks for most diabetics. Keeping track of food intake and adhering to drug doses can be challenging to maintain on a day-to-day basis. Fortunately, technology and medicine combine to support diabetic health! Applications or “Apps” are available for download on most electronic devices, helping organize valuable data like meals, blood sugar readings, medication times, and lots more! App technology allows for storing and easy accessibility of health information beneficial in the management of diabetes. WebMD comments on app technology stating, “Applications -- or "apps" -- can help you with nutrition advice, carb counting, tracking blood sugar levels, medication alerts and managing kids with diabetes.” Discover which apps best accommodate your lifestyle and health needs!

Continue reading
in Health 5124

In type 1 diabetes (juvenile diabetes) is an autoimmune condition in which the pancreas fails to produce insulin, a hormone needed for glucose to enter cells. Insulin administration maintains blood glucose control for people with type 1 diabetes. In type 2 diabetes (diabetes mellitus) insulin is produced yet not assimilated properly, leading to insulin resistance. The American Diabetes Association describes type 2 diabetes as the most common type of diabetes. Adhering to a diet plan and exercising may be sufficient for some individuals, while others require diabetic medications or insulin therapy. Your physician will determine suitable treatment options based on your lifestyle and health needs.

Continue reading
in Medicine 4469

The New England Journal of Medicine reports in their article, Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes, reports a randomized study on the effects of Onglyza (Saxagliptin) in diabetic patients with a history of established vascular disease. The study was conducted over a period of 2 years in 16,500 Type 2 diabetic patients from 26 countries.

Continue reading
in Medicine 3407

Please publish modules in offcanvas position.